A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Exelixis
Myeloid Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
Hefei TG ImmunoPharma Co., Ltd.
City of Hope Medical Center
Bristol-Myers Squibb
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tesaro, Inc.
Toray Industries, Inc
DEKA Biosciences
Eli Lilly and Company
Ono Pharmaceutical Co. Ltd
Servier
Emory University
Fate Therapeutics
Tempest Therapeutics
Fate Therapeutics
University of California, San Francisco
PACT Pharma, Inc.
Akamis Bio
Daiichi Sankyo
Bristol-Myers Squibb